Trade Summary

4 days ago, Rowland Thomas Andrew, serving as SVP, HEAD - ESTABLISHED BRANDS at Ani Pharmaceuticals Inc (ANIP), sold 4,772 shares at $74.91 per share, for a total transaction value of $357,471.00. Following this transaction, Rowland Thomas Andrew now holds 38,730 shares of ANIP.

This sale represents a 11.00% decrease in Rowland Thomas Andrew's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 2 days after the trade was made.

Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.